NEW YORK (Reuters Health) – For patients on maintenance prasugrel (Effient) therapy having percutaneous coronary intervention (PCI), a dose of 60 mg in the peri-PCI period achieves “faster…
NEW YORK (Reuters Health) – Adding the investigational agent perampanel to concomitant antiepilepsy therapy reduces seizure frequency in patients with refractory partial-onset seizures, according to the results of…
NEW YORK (Reuters Health) – Daily low-dose aspirin reduces not only cardiovascular mortality but also nonvascular mortality – and cancer mortality in particular — after relatively short duration…
NEW YORK (Reuters Health) – After about a year, patients with early aggressive rheumatoid arthritis have the same improvement in disease activity whether treated initially with methotrexate plus…
NEW YORK (Reuters Health) – The sedative effects of benzodiazepine exposure through breast milk appear to present minimal risk of central nervous system (CNS) depression in infants, results…
NEW YORK (Reuters Health) – A systematic review and meta-analysis provides “reasonable” support for the current practice of giving adjuvant therapy to patients with resected biliary tract cancer…
NEW YORK (Reuters Health) – Paracervical block is effective in decreasing pain associated with first-trimester surgical abortion, suggest results of a randomized controlled trial conducted in Portland, Oregon.…
NEW YORK (Reuters Health) – Patients having coronary artery bypass grafting (CABG) have fewer postoperative heart rhythm complications and recover faster if they are pretreated with a statin,…
NEW YORK (Reuters Health) – In the setting of primary percutaneous coronary intervention for ST segment-elevated MI, use of drug-eluting stents (DES) rather bare metal stents (BMS) is…
NEW YORK (Reuters Health) – A combined oral contraceptive containing nomegestrol acetate and 17beta-estradiol (E2) taken in a 24–4-day regimen is somewhat more effective in preventing pregnancy than…
